1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    












































































































    Quantification of Brain Damage in Cerebrotendinous Xanthomatosis with Magnetization Transfer MR Imaging | American Journal of Neuroradiology  
    



















    





























    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBRAIN

  
      

  
      
Quantification of Brain Damage in Cerebrotendinous Xanthomatosis with Magnetization Transfer MR Imaging
  
    	
Matilde Inglese, Nicola DeStefano, Elisabetta Pagani, Maria T. Dotti, Giancarlo Comi, Antonio Federico and Massimo Filippi

  
    	
American Journal of Neuroradiology March 2003,  24 (3) 495-500; 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. ↵
    Oftebro H, Björkhem I, Stormer FC, Pedersen JI. Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors. J Lipid Res 1981;22:632–640
    Abstract
  2. ↵
    Verrips A, Hoefsloot LH, Steenbergen CH, et al. Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 2000;123:908–919
    Abstract/FREE Full Text
  3. ↵
    Bjorkhem I, Boberg KM. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw-Hill,1995;2073–2099
  4. ↵
    Federico A, Dotti MT. Cerebrotendinous xanthomatosis. In: Vinken PJ, Bruyn GW, Moser HW, eds. Handbook of Clinical Neurology. Vol 66. Amsterdam: Elsevier Science,1996;599–613
  5. ↵
    Berginer VM, Berginer J, Korczyn AD, Tadmor R. Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neuroradiological study. J Neurol Sci 1994;122:102–108
    CrossRefPubMedWeb of Science
  6. Dotti MT, Federico A, Signorini E, et al. Cerebrotendinous xanthomatosis (van Bogaert Scherer Epstein disease): CT and MR findings. AJNR Am J Neuroradiol 1994;15:1721–1726
    Abstract/FREE Full Text
  7. Valk J, van der Knaap MS. Selective vulnerability in toxic encephalopathies and metabolic disorders. Riv Neuroradiol 1996;9:749–760
  8. ↵
    Barkhof F, Verrips A, Wesseling P, et al. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 2000;217:869–876
    PubMedWeb of Science
  9. ↵
    De Stefano N, Dotti MT, Mortilla M, Federico A. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 2001;124:121–131
    Abstract/FREE Full Text
  10. ↵
    Filippi M. In-vivo tissue characterization of multiple sclerosis and other white matter diseases using magnetic resonance-based techniques. J Neurol 2001;248:1019–1029
    CrossRefPubMedWeb of Science
  11. ↵
    Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 1984;311:1649–1652
    CrossRefPubMedWeb of Science
  12. Pedley TA, Emerson RG, Warner CL, Rowland LP, Salen G. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. Ann Neurol 1985;18:517–518
    CrossRefPubMedWeb of Science
  13. ↵
    Verrips A, Wevers RA, van Engelen BG, et al. Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. Metabolism 1999;48:233–238
    CrossRefPubMedWeb of Science
  14. ↵
    van Waesberghe JHT, Kamphorst W, De Groot CJA, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747–754
    CrossRefPubMedWeb of Science
  15. ↵
    van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632–636
    PubMedWeb of Science
  16. ↵
    Filippi M, Iannucci G, Tortorella C, et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999;52:588–594
    Abstract/FREE Full Text
  17. ↵
    Filippi M, Inglese M, Rovaris M, et al. Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study. Neurology 2000;55:940–946
    Abstract/FREE Full Text
  18. ↵
    Iannucci G, Dichgans M, Rovaris M, et al. Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy. Stroke 2001;32:643–648
    Abstract/FREE Full Text
  19. ↵
    Rovaris M, Viti B, Ciboddo G, et al. Brain involvement in systemic immune-mediated diseases: a magnetic resonance and magnetization transfer imaging study. J Neurol Neurosurg Psychiatry 1999;68:170–177
  20. ↵
    Bozzali M, Franceschi M, Falini A, et al. Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 2001;57:1135–1137
    Abstract/FREE Full Text
  21. ↵
    Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444–1452
    Abstract/FREE Full Text
  22. ↵
    Studholme C, Hill DLG, Hawkes DJ. Automated 3D registration of MR and PET brain images by multi-resolution optimisation of voxel similarity measures. Med Physics 1997;24:25–35
    CrossRefPubMedWeb of Science
  23. ↵
    Tortorella C, Viti B, Bozzali M, et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS. Neurology 2000;54:186–193
    Abstract/FREE Full Text
  24. ↵
    Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility in measuring new MR putative markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997;244:266–270
    CrossRefPubMedWeb of Science
  25. ↵
    Ashburner J, Friston KJ. Multimodal image coregistration and partitioning: a unified framework. Neuroimage 1997;6:209–217
    CrossRefPubMedWeb of Science
  26. ↵
    Cercignani M, Bozzali M, Iannucci G, Comi G, Filippi M. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:311–317
    Abstract/FREE Full Text
  27. ↵
    Iannucci G, Minicucci L, Rodegher M, Sormani MP, Comi G, Filippi M. Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T1, T2 and MT histograms. J Neurol Sci 1999;171:121–129
    CrossRefPubMedWeb of Science
  28. ↵
    Inglese M, Rovaris M, Bianchi S, et al. Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber’s hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 2001;70:444–449
    Abstract/FREE Full Text
  29. ↵
    Ferini-Strambi L, Bozzali M, Cercignani M, Oldani A, Zucconi M, Filippi M. Magnetization transfer and diffusion-weighted imaging in nocturnal frontal lobe epilepsy. Neurology 2000;54:2331–2333
    Abstract/FREE Full Text
  30. ↵
    Stahl WL, Sumi SM, Swanson PD. Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis. J Neurochem 1971;18:403–413
    CrossRefPubMed
  31. ↵
    Pop PH, Joosten E, van Spreeken A, et al. Neuroaxonal pathology of central and peripheral nervous system in cerebrotendinous xanthomatosis (CTX). Acta Neuropathol (Berl) 1984;64:259–264
    CrossRefPubMed
  32. ↵
    Soffer D, Benharroch D, Berginer V. The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature. Acta Neuropathol (Berl) 1995;90:213–220
    PubMed
  33. ↵
    Philippart M, van Bogaert L. Cerebrotendinous xanthomatosis: a generalized disorder of cholestanol metabolism. Trans Am Neurol Assoc 1969;94:322–324
    PubMed
  34. ↵
    Elleder M, Michalec C, Jirasek A, Khun K, Havlova M, Ranny M. Membranocystic lesion in the brain in cerebrotendinous xanthomatosis: Histochemical and ultrastructural study with evidence of its ceroid nature. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;57:367–374
    PubMedWeb of Science
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Quantification of Brain Damage in Cerebrotendinous Xanthomatosis with Magnetization Transfer MR Imaging
  
    	
Matilde Inglese, Nicola DeStefano, Elisabetta Pagani, Maria T. Dotti, Giancarlo Comi, Antonio Federico, Massimo Filippi

  
    	
American Journal of Neuroradiology Mar 2003, 24 (3) 495-500; 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement